Basic information |
Metabolite name | LysoPC(16:1/0:0) |
HMDB0010383 | |
C04230 | |
24779461 | |
Synonyms | LysoPC(16:1(9Z)/0:0); |
No. of studies | 14 |
Relationship between LysoPC(16:1/0:0) and depression (count: 14) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Up |
Study M095 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
Study M1117 | Type1 | MDD group vs. control group, Russian cohort | Plasma | Human | Down |
Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
Study M582 | Type1 | CUMS group vs. control group | Serum | C57BL/6N mouse | Down |
Study M582 | Type3 | control + fluoxetine group vs. control group | Serum | C57BL/6N mouse | Up |
Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Up |
Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
Study M858 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |